par Franchimont, Denis 
;Van Laethem, Jean-Luc ;Devière, Jacques
Référence Gastrointestinal endoscopy clinics of North America, 13, 3, page (457-466)
Publication Publié, 2003-07
;Van Laethem, Jean-Luc ;Devière, Jacques Référence Gastrointestinal endoscopy clinics of North America, 13, 3, page (457-466)
Publication Publié, 2003-07
Article révisé par les pairs
| Résumé : | Despite the availability of many clinical trials, there is no evidence that APC has any role in the management of Barrett's esophagus. Ablation therapy is not indicated for nondysplastic Barrett's esophagus (and this is true, whatever the technique used), and it should not be performed outside of a carefully designed and approved clinical trial. Indeed, these patients have a low risk of cancer, and there is no evidence that Barrett's esophagus ablation will be of any benefit for these patients. In some cases, APC could be of some help, especially for treating short segments of dysplastic Barrett's esophagus. In this field, however, it competes with the growing indication of mucosectomy, which clearly offers advantages in terms of treatment's quality control assessment. |
